Drug Topics

DECEMBER 12, 2024

Lourdes Cross, PharmD, BCACP, CDCES, discussed chronic obstructive pulmonary disease and how pharmacists are positioned to help patients exacerbations.

469

469

The Checkup by Singlecare

DECEMBER 10, 2024

Trulicity (dulaglutide) and Ozempic (semaglutide) are both brand-name medications approved by the Food and Drug Administration (FDA) to help treat Type 2 diabetes. Because these drugs suppress appetite, some healthcare providers prescribe them off-label for weight loss. However, another medication with the same active ingredient as Ozempic has been FDA approved for weight loss and is sold under the brand name Wegovy.

Dosage 98

Dosage Insurance Coverage Labelling Insurance 98

STAT

DECEMBER 8, 2024

SAN DIEGO — Pfizer’s abrupt withdrawal of its sickle cell drug Oxybryta over safety concerns was called “tone deaf” during a panel discussion among sickle cell experts Saturday at STAT@ASH , which took place during the American Society of Hematology’s annual meeting. They said patients were despondent over how suddenly the drug was pulled from the market in September because there had been no clear indication of problems in advance of the announcement.

114

114

The Guardian - Pharmaceutical Industry

DECEMBER 7, 2024

The King Kong of weight loss drugs will be available on the NHS but only patients with most need will get it Mounjaro, known as the King Kong of weight loss drugs, will be available to patients on the NHS, but this week it was announced the medication will be prioritised to people with the highest needs with the rollout expected to extend over 12 years.

82

82

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmafile

DECEMBER 12, 2024

12 December 2024 London, UK, and Palo Alto, CA, US Deep Science Ventures, a UK-based venture studio, and General Inception, a US-based venture studio, today announced a collaboration to create a company focused on developing novel treatments for fibrosis. Widely recognised as an area of significant unmet need, Deep Science Ventures and General […] The post Deep Science Ventures and General Inception collaborate to create fibrosis-focused therapeutics company appeared first on Pharmafile.

59

59

The FDA Law Blog

DECEMBER 9, 2024

On Wednesday, December 11, Hyman, Phelps & McNamara, P.C. (HPM) and Riparian LLC will co-host a webinar on an important CMS rule imposing penalties for misclassification of drugs and other reporting errors under the Medicaid Drug Rebate Program. (See our post on this rule here.) The Webinar will explore the CMS rule and provide actionable recommendations for manufacturers on how to navigate the new requirements.

59

59

Drug Topics

DECEMBER 13, 2024

US Senators introduced the bipartisan bill addressing pharmacy benefit managers and their affiliated pharmacies.

469

469

PharmaVoice

DECEMBER 13, 2024

Amid the DEI backlash in corporate America, pharma leaders are quietly adjusting tactics.

246

246

The FDA Law Blog

DECEMBER 11, 2024

On Wednesday, December 11, Hyman, Phelps & McNamara, P.C. (HPM) and Riparian LLC will co-host a webinar on an important CMS rule imposing penalties for misclassification of drugs and other reporting errors under the Medicaid Drug Rebate Program. (See our post on this rule here.) The Webinar will explore the CMS rule and provide actionable recommendations for manufacturers on how to navigate the new requirements.

59

59

STAT

DECEMBER 11, 2024

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After all, we have made it this far, so we are determined to hang on for another couple of days. And why not? The alternatives — at least those we can identify — are not so appetizing. And what better way to make the time fly than to keep busy.

Insurance 114

Insurance 114

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Drug Topics

DECEMBER 8, 2024

Navigating Cannabis use requires more than just an understanding of the endocannabinoid system.

469

469

IDStewardship

DECEMBER 13, 2024

In this article an experienced antimicrobial stewardship pharmacist discusses lessons learned from navigating antimicrobial stewardship metrics. Authored by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article posted 13 December 2024 If you cannot measure it, you cannot determine if you have changedit. Antimicrobial stewardship metrics are essential for identifying, acting on, and re-evaluating opportunities to enhance the safe and appropriateuse of antibiotics.

Communication 225

Communication Medical Records Documentation 225

PharmaVoice

DECEMBER 11, 2024

The agency has yet to make a decision about keeping tirzepatide on or off of its shortage list — letting compound pharmacies continue their lucrative operations for now.

Compounding 162

Compounding Compounding Pharmacies FDA 162

STAT

DECEMBER 10, 2024

The Ohio Supreme Court ruled that three of the largest pharmacy chain operators in the U.S. could not be held liable under a state nuisance law for contributing to the long-running opioid crisis. In a 5-to-2 vote, the court determined that the law barred two Ohio counties from obtaining a $650.9 million judgement that was won in a federal court against CVS Health, Walgreens, and Walmart.

143

143

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Drug Topics

DECEMBER 11, 2024

Ethan Melillo, PharmD, CDOE, senior manager of Integrated Health at LOral, provides some of his favorite recommendations to help with irritated skin.

466

466

Pharmacy Times

DECEMBER 9, 2024

Adults with epilepsy are underrepresented in most CBD trials, including common etiologies.

149

149

Pharmaceutical Technology

DECEMBER 9, 2024

Shares in WuXi AppTec, one of those implicated in the Chinese biotech blacklisting legislation, surged following the omission.

122

122

STAT

DECEMBER 11, 2024

A proposed Senate bill that would prohibit companies that control health insurers or pharmacy benefit managers from owning pharmacies rattled investors on Wednesday, but some Wall Street analysts believe the legislation is unlikely to gain much traction, at least for now. The bipartisan bill , which would require divestiture within three years, is aimed at what the lawmakers call an “inherent conflict of interest” that has forced Americans to pay more for medicines and hastened the

Insurance 133

Insurance Independent Pharmacies 133

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Drug Topics

DECEMBER 12, 2024

Nina Vadiei, PharmD, BCPP, discusses some of the challenges she faces working with forensic patients who have been charged with a crime and have severe mental illness.

359

359

Pharmacy Times

DECEMBER 8, 2024

By identifying patients at high risk for progressing to severe disease and counseling them on their treatment options, pharmacists empower patients to make informed decisions about their treatment.

149

149

Fierce Pharma

DECEMBER 13, 2024

Two days after the FDA revealed that it had halted enrollment in trials of respiratory syncytial virus (RSV) vaccines that involve young children, experts from an FDA advisory panel expressed their | An FDA advisory committeeexamining the halt of a trial of two Moderna respiratory syncytial virus (RSV) vaccines because of severe lower respiratory tract infections (LRTIs)echoed frustration in knowledge gaps about the disease and said that more testing is needed.

Vaccines 117

Vaccines FDA 117

STAT

DECEMBER 10, 2024

Eli Lilly, the company that makes the blockbuster weight loss treatment Zepbound, will start studying its obesity products as treatments for alcohol and drug abuse, making it the first major drugmaker to do so, CEO David Ricks said Tuesday. Emerging research suggests that GLP-1 drugs — Zepbound is one such treatment — not only reduce food cravings but may also suppress desires for other substances.

145

145

Drug Topics

DECEMBER 13, 2024

See whats trending in pharmacy with a preview of the Total Pharmacy December issue.

247

247

Pharmacy Times

DECEMBER 8, 2024

The phase 3 AMPLIFY trial demonstrates that fixed-duration regimens of acalabrutinib and venetoclax, with or without obinutuzumab, significantly improve progression-free survival and deliver manageable safety profiles compared to chemoimmunotherapy in treatment-naive chronic lymphocytic leukemia (CLL).

144

144

Fierce Pharma

DECEMBER 12, 2024

GLP-1 agonists have taken the pharma world by storm, and Novo Nordisk has been at the forefront of it all thanks to blockbuster drug semaglutide, which it sells as Ozempic, Wegovy and Rybelsus. | This week on The Top Line, we hear from Novo Nordisk CSO Marcus Schindler about his role at the Danish pharma and whats next for the GLP-1 drug class.

117

117

STAT

DECEMBER 9, 2024

What happens when two computer scientists and a former stem cell researcher become friends while working their way up the venture capital corporate ladder and decide to start their own firm? Well, in Dimension’s case, they end up investing in some buzzy AI startups, counseling pharmaceutical companies, ribbing one another about expense reports, and — as of Monday — are able to raise $500 million for their second fund.

Pharmaceutical Companies 120

Pharmaceutical Companies Pharmaceutical Companies 120

Drug Topics

DECEMBER 13, 2024

A conversation with Nina Vadiei, PharmD, BCPP, clinical associate professor in the Division of Pharmacotherapy at University of Texas at Austin College of Pharmacy and a clinical pharmacy specialist in psychiatry at the San Antonio State Hospital.

Hospitals 247

Hospitals 247

Pharmacy Times

DECEMBER 11, 2024

The combination vaccine candidates will be evaluated in 2 separate phase 1/2 clinical trials.

Vaccines 139

Vaccines FDA 139

Fierce Pharma

DECEMBER 13, 2024

Disgraced former OxyContin marketer Purdue Pharma is on the hook for billions after agreeing to settle cases that held the company responsible for fueling the U.S. opioid crisis. | McKinsey will pay $650 million to settle with the U.S. Department of Justice, which was investigating the companys efforts to help Purdue increase its opioid sales. In exchange, the DOJ will drop its charges.

109

109

STAT

DECEMBER 11, 2024

Eli Lilly, which has been directing patients to various telehealth sites as it sells its blockbuster obesity medication Zepbound, is broadening its reach, announcing a partnership Wednesday with major telehealth platform Ro Health. Under the new agreement, patients will be able to order vials of Zepbound through Ro’s app. Previously, Lilly had only made these vials, which are priced lower than its injectable pens, available to patients with prescriptions ordering directly through an onlin

Compounding 128

Compounding Compounding Pharmacies 128

Drug Topics

DECEMBER 13, 2024

Denise Kelley, PharmD, BCPS, FASHP, joined Drug Topics to discuss various medications for chronic kidney disease and their common adverse reactions.

Adverse Reactions 247

Adverse Reactions 247

Pharmacy Times

DECEMBER 11, 2024

According to the report, 75% of survey participants expect pharmacists to oversee these therapies and 58% expect Medicare will require pharmacist involvement.

139

139

Pharmaceutical Technology

DECEMBER 12, 2024

In the letter, 77 Nobel Prize winners argue that appointing RFK as Secretary of HHS would put the US publics health in jeopardy.

105

105